img

Global Porcine Vaccines Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Vaccines Market Insights, Forecast to 2034

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
Global Porcine Vaccines market is expected to reach to US$ 1439 million in 2024, with a positive growth of %, compared with US$ 1345 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Porcine Vaccines industry is evaluated to reach US$ 2099.7 million in 2029. The CAGR will be 6.5% during 2024 to 2029.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Covers
This report presents an overview of global Porcine Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Porcine Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other

Segment by Application


Government Tender
Market Sales

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Porcine Vaccines plant distribution, commercial date of Porcine Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Porcine Vaccines introduction, etc. Porcine Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Porcine Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Porcine Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Porcine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Market by Application
1.3.1 Global Porcine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Porcine Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Porcine Vaccines Revenue by Region
2.2.1 Global Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Porcine Vaccines Revenue by Region (2018-2024)
2.2.3 Global Porcine Vaccines Revenue by Region (2024-2029)
2.2.4 Global Porcine Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Porcine Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Porcine Vaccines Sales by Region
2.4.1 Global Porcine Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Porcine Vaccines Sales by Region (2018-2024)
2.4.3 Global Porcine Vaccines Sales by Region (2024-2029)
2.4.4 Global Porcine Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Porcine Vaccines Sales by Manufacturers
3.1.1 Global Porcine Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Porcine Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Vaccines in 2022
3.2 Global Porcine Vaccines Revenue by Manufacturers
3.2.1 Global Porcine Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Vaccines Revenue in 2022
3.3 Global Key Players of Porcine Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Porcine Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Porcine Vaccines Sales by Type
4.1.1 Global Porcine Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Porcine Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Porcine Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Porcine Vaccines Revenue by Type
4.2.1 Global Porcine Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Vaccines Price by Type
4.3.1 Global Porcine Vaccines Price by Type (2018-2024)
4.3.2 Global Porcine Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Porcine Vaccines Sales by Application
5.1.1 Global Porcine Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Porcine Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Porcine Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Porcine Vaccines Revenue by Application
5.2.1 Global Porcine Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Vaccines Price by Application
5.3.1 Global Porcine Vaccines Price by Application (2018-2024)
5.3.2 Global Porcine Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Porcine Vaccines Market Size by Type
6.1.1 US & Canada Porcine Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Porcine Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Porcine Vaccines Market Size by Application
6.2.1 US & Canada Porcine Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Porcine Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Porcine Vaccines Market Size by Country
6.3.1 US & Canada Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Porcine Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Porcine Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Porcine Vaccines Market Size by Type
7.1.1 Europe Porcine Vaccines Sales by Type (2018-2029)
7.1.2 Europe Porcine Vaccines Revenue by Type (2018-2029)
7.2 Europe Porcine Vaccines Market Size by Application
7.2.1 Europe Porcine Vaccines Sales by Application (2018-2029)
7.2.2 Europe Porcine Vaccines Revenue by Application (2018-2029)
7.3 Europe Porcine Vaccines Market Size by Country
7.3.1 Europe Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Porcine Vaccines Sales by Country (2018-2029)
7.3.3 Europe Porcine Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Porcine Vaccines Market Size
8.1.1 China Porcine Vaccines Sales (2018-2029)
8.1.2 China Porcine Vaccines Revenue (2018-2029)
8.2 China Porcine Vaccines Market Size by Application
8.2.1 China Porcine Vaccines Sales by Application (2018-2029)
8.2.2 China Porcine Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Porcine Vaccines Market Size by Type
9.1.1 Asia Porcine Vaccines Sales by Type (2018-2029)
9.1.2 Asia Porcine Vaccines Revenue by Type (2018-2029)
9.2 Asia Porcine Vaccines Market Size by Application
9.2.1 Asia Porcine Vaccines Sales by Application (2018-2029)
9.2.2 Asia Porcine Vaccines Revenue by Application (2018-2029)
9.3 Asia Porcine Vaccines Sales by Region
9.3.1 Asia Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Porcine Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Porcine Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Porcine Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Porcine Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Porcine Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Porcine Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Porcine Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Jinyu Bio-Technology
11.3.1 Jinyu Bio-Technology Company Information
11.3.2 Jinyu Bio-Technology Overview
11.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Jinyu Bio-Technology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jinyu Bio-Technology Recent Developments
11.4 CAHIC
11.4.1 CAHIC Company Information
11.4.2 CAHIC Overview
11.4.3 CAHIC Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 CAHIC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CAHIC Recent Developments
11.5 Tecon
11.5.1 Tecon Company Information
11.5.2 Tecon Overview
11.5.3 Tecon Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Tecon Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tecon Recent Developments
11.6 Zoetis
11.6.1 Zoetis Company Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Zoetis Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zoetis Recent Developments
11.7 Ceva
11.7.1 Ceva Company Information
11.7.2 Ceva Overview
11.7.3 Ceva Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Ceva Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Recent Developments
11.8 Hile Bio
11.8.1 Hile Bio Company Information
11.8.2 Hile Bio Overview
11.8.3 Hile Bio Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Hile Bio Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hile Bio Recent Developments
11.9 Chopper Biology
11.9.1 Chopper Biology Company Information
11.9.2 Chopper Biology Overview
11.9.3 Chopper Biology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Chopper Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Chopper Biology Recent Developments
11.10 WINSUN
11.10.1 WINSUN Company Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 WINSUN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WINSUN Recent Developments
11.11 Hipra
11.11.1 Hipra Company Information
11.11.2 Hipra Overview
11.11.3 Hipra Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hipra Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hipra Recent Developments
11.12 Ringpu Biology
11.12.1 Ringpu Biology Company Information
11.12.2 Ringpu Biology Overview
11.12.3 Ringpu Biology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Ringpu Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ringpu Biology Recent Developments
11.13 DHN
11.13.1 DHN Company Information
11.13.2 DHN Overview
11.13.3 DHN Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 DHN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 DHN Recent Developments
11.14 CAVAC
11.14.1 CAVAC Company Information
11.14.2 CAVAC Overview
11.14.3 CAVAC Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 CAVAC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CAVAC Recent Developments
11.15 Virbac
11.15.1 Virbac Company Information
11.15.2 Virbac Overview
11.15.3 Virbac Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Virbac Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Virbac Recent Developments
11.16 HVRI
11.16.1 HVRI Company Information
11.16.2 HVRI Overview
11.16.3 HVRI Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 HVRI Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 HVRI Recent Developments
11.17 Bioveta
11.17.1 Bioveta Company Information
11.17.2 Bioveta Overview
11.17.3 Bioveta Porcine Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Bioveta Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Bioveta Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Porcine Vaccines Industry Chain Analysis
12.2 Porcine Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Vaccines Production Mode & Process
12.4 Porcine Vaccines Sales and Marketing
12.4.1 Porcine Vaccines Sales Channels
12.4.2 Porcine Vaccines Distributors
12.5 Porcine Vaccines Customers
13 Market Dynamics
13.1 Porcine Vaccines Industry Trends
13.2 Porcine Vaccines Market Drivers
13.3 Porcine Vaccines Market Challenges
13.4 Porcine Vaccines Market Restraints
14 Key Findings in The Global Porcine Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of CSF Vaccines
Table 3. Major Manufacturers of FMD Vaccines
Table 4. Major Manufacturers of Porcine Circovirus Vaccines
Table 5. Major Manufacturers of PRRS Vaccines
Table 6. Major Manufacturers of Other
Table 7. Global Porcine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Porcine Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Porcine Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Porcine Vaccines Revenue Market Share by Region (2018-2024)
Table 12. Global Porcine Vaccines Revenue Market Share by Region (2024-2029)
Table 13. Global Porcine Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Porcine Vaccines Sales by Region (2018-2024) & (M Units)
Table 15. Global Porcine Vaccines Sales by Region (2024-2029) & (M Units)
Table 16. Global Porcine Vaccines Sales Market Share by Region (2018-2024)
Table 17. Global Porcine Vaccines Sales Market Share by Region (2024-2029)
Table 18. Global Porcine Vaccines Sales by Manufacturers (2018-2024) & (M Units)
Table 19. Global Porcine Vaccines Sales Share by Manufacturers (2018-2024)
Table 20. Global Porcine Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Porcine Vaccines Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Porcine Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Porcine Vaccines Price by Manufacturers 2018-2024 (USD/K Unit)
Table 24. Global Porcine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Porcine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2022)
Table 26. Global Key Manufacturers of Porcine Vaccines, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Porcine Vaccines, Product Offered and Application
Table 28. Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 31. Global Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 32. Global Porcine Vaccines Sales Share by Type (2018-2024)
Table 33. Global Porcine Vaccines Sales Share by Type (2024-2029)
Table 34. Global Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Porcine Vaccines Revenue Share by Type (2018-2024)
Table 37. Global Porcine Vaccines Revenue Share by Type (2024-2029)
Table 38. Porcine Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 39. Global Porcine Vaccines Price Forecast by Type (2024-2029) & (USD/K Unit)
Table 40. Global Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 41. Global Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 42. Global Porcine Vaccines Sales Share by Application (2018-2024)
Table 43. Global Porcine Vaccines Sales Share by Application (2024-2029)
Table 44. Global Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Porcine Vaccines Revenue Share by Application (2018-2024)
Table 47. Global Porcine Vaccines Revenue Share by Application (2024-2029)
Table 48. Porcine Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 49. Global Porcine Vaccines Price Forecast by Application (2024-2029) & (USD/K Unit)
Table 50. US & Canada Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 51. US & Canada Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 52. US & Canada Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 55. US & Canada Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 56. US & Canada Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Porcine Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 62. US & Canada Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 63. Europe Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 64. Europe Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 65. Europe Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 68. Europe Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 69. Europe Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Porcine Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 75. Europe Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 76. China Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 77. China Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 78. China Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 81. China Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 82. China Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 85. Asia Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 86. Asia Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 89. Asia Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 90. Asia Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Porcine Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Porcine Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Porcine Vaccines Sales by Region (2018-2024) & (M Units)
Table 96. Asia Porcine Vaccines Sales by Region (2024-2029) & (M Units)
Table 97. Middle East, Africa and Latin America Porcine Vaccines Sales by Type (2018-2024) & (M Units)
Table 98. Middle East, Africa and Latin America Porcine Vaccines Sales by Type (2024-2029) & (M Units)
Table 99. Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Porcine Vaccines Sales by Application (2018-2024) & (M Units)
Table 102. Middle East, Africa and Latin America Porcine Vaccines Sales by Application (2024-2029) & (M Units)
Table 103. Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Porcine Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 109. Middle East, Africa and Latin America Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 110. Merck Company Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 113. Merck Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Recent Developments
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 118. Boehringer Ingelheim Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Description and Major Businesses
Table 122. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 123. Jinyu Bio-Technology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Jinyu Bio-Technology Recent Developments
Table 125. CAHIC Company Information
Table 126. CAHIC Description and Major Businesses
Table 127. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 128. CAHIC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CAHIC Recent Developments
Table 130. Tecon Company Information
Table 131. Tecon Description and Major Businesses
Table 132. Tecon Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 133. Tecon Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tecon Recent Developments
Table 135. Zoetis Company Information
Table 136. Zoetis Description and Major Businesses
Table 137. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 138. Zoetis Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Zoetis Recent Developments
Table 140. Ceva Company Information
Table 141. Ceva Description and Major Businesses
Table 142. Ceva Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 143. Ceva Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Ceva Recent Developments
Table 145. Hile Bio Company Information
Table 146. Hile Bio Description and Major Businesses
Table 147. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 148. Hile Bio Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Hile Bio Recent Developments
Table 150. Chopper Biology Company Information
Table 151. Chopper Biology Description and Major Businesses
Table 152. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 153. Chopper Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Chopper Biology Recent Developments
Table 155. WINSUN Company Information
Table 156. WINSUN Description and Major Businesses
Table 157. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 158. WINSUN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. WINSUN Recent Developments
Table 160. Hipra Company Information
Table 161. Hipra Description and Major Businesses
Table 162. Hipra Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 163. Hipra Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Hipra Recent Developments
Table 165. Ringpu Biology Company Information
Table 166. Ringpu Biology Description and Major Businesses
Table 167. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 168. Ringpu Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Ringpu Biology Recent Developments
Table 170. DHN Company Information
Table 171. DHN Description and Major Businesses
Table 172. DHN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 173. DHN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. DHN Recent Developments
Table 175. CAVAC Company Information
Table 176. CAVAC Description and Major Businesses
Table 177. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 178. CAVAC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. CAVAC Recent Developments
Table 180. Virbac Company Information
Table 181. Virbac Description and Major Businesses
Table 182. Virbac Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 183. Virbac Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Virbac Recent Developments
Table 185. HVRI Company Information
Table 186. HVRI Description and Major Businesses
Table 187. HVRI Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 188. HVRI Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. HVRI Recent Developments
Table 190. Bioveta Company Information
Table 191. Bioveta Description and Major Businesses
Table 192. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 193. Bioveta Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Bioveta Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Porcine Vaccines Distributors List
Table 198. Porcine Vaccines Customers List
Table 199. Porcine Vaccines Market Trends
Table 200. Porcine Vaccines Market Drivers
Table 201. Porcine Vaccines Market Challenges
Table 202. Porcine Vaccines Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Vaccines Product Picture
Figure 2. Global Porcine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Porcine Vaccines Market Share by Type in 2022 & 2029
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Porcine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Porcine Vaccines Market Share by Application in 2022 & 2029
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Porcine Vaccines Report Years Considered
Figure 14. Global Porcine Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Porcine Vaccines Revenue 2018-2029 (US$ Million)
Figure 16. Global Porcine Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Porcine Vaccines Revenue Market Share by Region (2018-2029)
Figure 18. Global Porcine Vaccines Sales 2018-2029 ((M Units)
Figure 19. Global Porcine Vaccines Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Porcine Vaccines Sales YoY (2018-2029) & (M Units)
Figure 21. US & Canada Porcine Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Porcine Vaccines Sales YoY (2018-2029) & (M Units)
Figure 23. Europe Porcine Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Porcine Vaccines Sales YoY (2018-2029) & (M Units)
Figure 25. China Porcine Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Porcine Vaccines Sales YoY (2018-2029) & (M Units)
Figure 27. Asia (excluding China) Porcine Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Porcine Vaccines Sales YoY (2018-2029) & (M Units)
Figure 29. Middle East, Africa and Latin America Porcine Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Porcine Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Porcine Vaccines in the World: Market Share by Porcine Vaccines Revenue in 2022
Figure 32. Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 34. Global Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 35. Global Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 36. Global Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Porcine Vaccines Revenue Share by Country (2018-2029)
Figure 42. US & Canada Porcine Vaccines Sales Share by Country (2018-2029)
Figure 43. U.S. Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 46. Europe Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 47. Europe Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 48. Europe Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 49. Europe Porcine Vaccines Revenue Share by Country (2018-2029)
Figure 50. Europe Porcine Vaccines Sales Share by Country (2018-2029)
Figure 51. Germany Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. France Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. UK Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 56. China Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 57. China Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 58. China Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 59. China Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 60. Asia Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 61. Asia Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 62. Asia Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 63. Asia Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 64. Asia Porcine Vaccines Revenue Share by Region (2018-2029)
Figure 65. Asia Porcine Vaccines Sales Share by Region (2018-2029)
Figure 66. Japan Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 70. India Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Porcine Vaccines Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Porcine Vaccines Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Porcine Vaccines Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Porcine Vaccines Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Porcine Vaccines Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Porcine Vaccines Sales Share by Country (2018-2029)
Figure 77. Brazil Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Porcine Vaccines Revenue (2018-2029) & (US$ Million)
Figure 82. Porcine Vaccines Value Chain
Figure 83. Porcine Vaccines Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed